🇺🇸 FDA
Patent

US 10597382

Tetrazole containing apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof

granted A61PA61P1/16A61P13/12

Quick answer

US patent 10597382 (Tetrazole containing apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof) held by Enanta Pharmaceuticals, Inc. expires Mon Mar 19 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Enanta Pharmaceuticals, Inc.
Grant date
Tue Mar 24 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 19 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
17
CPC classes
A61P, A61P1/16, A61P13/12, A61P3/10